Patch tests at 1% and 5% came back negative in test panels, and creams at typical use levels did not cause allergic reactions across large groups of people
After months of continuously collecting data on GLP-1 usage, the CivicSciences GLP-1 Consumer Tracker now includes insights from 118K GLP-1 users, allowing us to delve into the far-reaching effects these medications have on society, culture, and the economy
Lawsuits allege that Saxenda, like other GLP-1 receptor agonist drugs, has caused serious gastrointestinal injuries, severe vomiting, and increased risk of stomach paralysis
When exploring pain management options it is worth exploring how strong is tramadol compared to other painkillers
For the majority of healthy individuals, there is little to no risk associated with the use of peptides
5 Summary Tirzepatide is a novel dual agonist of GIP and GLP-1 that shows promise to fill the treatment gap in managing diabesity